Poland· PL-100521672
Ziihera
A her2 (human epidermal growth factor receptor 2) inhibitors product containing zanidatamab, registered in Poland by Jazz Pharmaceuticals Ireland Ltd.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Zanidatamab
- Manufacturer
- Jazz Pharmaceuticals Ireland Ltd
- Country
- Poland (PL)
- ATC code
- L01FD
- ATC class
- HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zanidatamab in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaZIIHERAJazz Pharmaceuticals Ireland Ltd, Dublin
- FinlandZiiheraJazz Pharmaceuticals Ireland Limited
- BelgiumZiihera 300 mgJazz Pharmaceuticals Ireland
- IrelandZiihera 300 mg powder for concentrate for solution for infusionJazz Pharmaceuticals Ireland Limited
- IcelandZiiheraJazz Pharmaceuticals Ireland Limited
- SwedenZiihera 300 mg Pulver till koncentrat till infusionsvätska, lösningJazz Pharmaceuticals Ireland Limited
- United KingdomZiihera 300mg powder for concentrate for solution for infusion vialsJazz Pharmaceuticals UK Ltd
- United StatesZIIHERAJazz Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ziihera
- Liechtenstein · Ziihera
- Norway · Ziihera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a42b322-e218-49ac-b3fc-a091807346e1 GET /v1/drugs/2a42b322-e218-49ac-b3fc-a091807346e1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania koncentratu roztworu do infuzji",
"source": "urpl",
"strength": "300 mg",
"packaging": "Rpz ¦ EU/1/25/1931/001 ¦ 162904\n1 fiol. 20 ml\nRpz ¦ EU/1/25/1931/002 ¦ 162905\n2 fiol. 20 ml",
"substance": "Zanidatamab 300 mg",
"common_name": "Zanidatamab",
"pl_product_id": "100521672",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about zanidatamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.